Manipal Hospitals appears to be recalibrating its financial expectations as it gears up for a highly anticipated market debut. Recent reports indicate the healthcare provider is scaling back its initial valuation targets, which were previously pegged between $10 billion and $12 billion.
Despite this downward adjustment, industry analysts remain optimistic about the firm's trajectory. The move is viewed as a strategic maneuver to ensure a successful reception from institutional investors in an increasingly cautious economic climate.
The upcoming listing is widely expected to be the most significant public offering in India for 2026. It is set to comfortably surpass the recent $1 billion IPO from SBI Funds, signaling strong investor appetite for top-tier healthcare assets.
As the company finalizes its documentation, the market is watching closely to see how this valuation shift impacts overall investor sentiment and the broader healthcare sector's performance on the public exchanges.
